Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis.

about

Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis.

Item

http://www.wikidata.org/entity/Q55200540

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Outcome evaluation of a pharma ...... patients with cystic fibrosis.

@en

Outcome evaluation of a pharma ...... patients with cystic fibrosis.

@nl

type

Item

label

Outcome evaluation of a pharma ...... patients with cystic fibrosis.

@en

Outcome evaluation of a pharma ...... patients with cystic fibrosis.

@nl

prefLabel

Outcome evaluation of a pharma ...... patients with cystic fibrosis.

@en

Outcome evaluation of a pharma ...... patients with cystic fibrosis.

@nl

P1476

Outcome evaluation of a pharma ...... patients with cystic fibrosis

@en

P2093

Alexis Parente

http://www.w3.org/2001/XMLSchema#string

Darren McLane

http://www.w3.org/2001/XMLSchema#string

Francis Staskon

http://www.w3.org/2001/XMLSchema#string

Gregory S Sawicki

http://www.w3.org/2001/XMLSchema#string

Karl M Kilgore

http://www.w3.org/2001/XMLSchema#string

Nishita Hira

http://www.w3.org/2001/XMLSchema#string

Seung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing Emergency Department Use Among Medicaid and Commercial Patients Using All-Payer All-Claims Data.

Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis.

Longitudinal association between medication adherence and lung health in people with cystic fibrosis.

Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents

Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis

Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes.

Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1.

Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis.

Ivacaftor: a review of its use in patients with cystic fibrosis.

The Geographic Impact on Hospitalization in Patients with Cystic Fibrosis.

P304

720-727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PPUL.23978

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heather S Kirkham

P577

2018-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29512893

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

6001460

http://www.w3.org/2001/XMLSchema#string